In the last 40 years, advances in protein engineering and evolution have prompted the application of biocatalysts in the synthesis of active pharmaceutical ingredients (API), as well as fine and bulk chemicals for the agrochemical, food, biofuel, and pharmaceutical industries. Computational chemistry methodologies in conjunction with smart variant library generation and high-throughput screening are fueling the development of a new generation of rationally designed biocatalysts with enhanced selectivity and specificity at a fraction of the time and cost of what was achievable a mere decade ago.

Utilisation de diverses séquences natives et d’évolution dirigée pour améliorer l’activité enzymatique sur les réactions ciblées

Optimisez vos chances d’obtenir une synthèse de gène et une expérimentation en aval réussies grâce à ces conseils de conception.